Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Metra

Showing results (141-150 of 1,328) with videos related to

Pageof 133
Sort By:
European Journal of Heart Failure|October 30, 2019
October 2019 at a glance: epidemiology, prevention, and modes of deathMarianna Adamo, Carlo Mario Lombardi, Marco Metra
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|October 10, 2022
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hopeMatteo Pagnesi, Antonio M Sammartino, Marco Metra
European Journal of Heart Failure|November 11, 2003
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivololSavina Nodari, Marco Metra, Livio Dei Cas
European Journal of Heart Failure|November 21, 2019
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatmentMarianna Adamo, Carlo Mario Lombardi, Marco Metra
European Journal of Heart Failure|July 15, 2021
Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each otherStephen J Greene, Javed Butler, Marco Metra
European Journal of Heart Failure|March 29, 2020
March 2020 at a glance: heart failure with preserved ejection fraction, left atrial myopathy, atrial fibrillation and cardiac amyloidosisMarianna Adamo, Carlo Mario Lombardi, Marco Metra
Expert Review of Cardiovascular Therapy|January 3, 2018
Negotiating renal dysfunction when treating patients with heart failureValentina Carubelli, Marco Metra, Lars H Lund
European Heart Journal|August 18, 2022
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?Bertram Pitt, Deepak L Bhatt, Marco Metra
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Current guidelines in the pharmacological management of chronic heart failureMarco Metra, Savina Nodari, Livio Dei Cas
JAMA Cardiology|August 22, 2020
Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease-ReplyRiccardo M Inciardi, Laura Lupi, Marco Metra
Pageof 133

Showing results (141-150 of 1,328) with videos related to

Sort By:
Pageof 133
European Journal of Heart Failure|October 30, 2019
October 2019 at a glance: epidemiology, prevention, and modes of deathMarianna Adamo, Carlo Mario Lombardi, Marco Metra
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|October 10, 2022
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hopeMatteo Pagnesi, Antonio M Sammartino, Marco Metra
European Journal of Heart Failure|November 11, 2003
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivololSavina Nodari, Marco Metra, Livio Dei Cas
European Journal of Heart Failure|November 21, 2019
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatmentMarianna Adamo, Carlo Mario Lombardi, Marco Metra
European Journal of Heart Failure|July 15, 2021
Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each otherStephen J Greene, Javed Butler, Marco Metra
European Journal of Heart Failure|March 29, 2020
March 2020 at a glance: heart failure with preserved ejection fraction, left atrial myopathy, atrial fibrillation and cardiac amyloidosisMarianna Adamo, Carlo Mario Lombardi, Marco Metra
Expert Review of Cardiovascular Therapy|January 3, 2018
Negotiating renal dysfunction when treating patients with heart failureValentina Carubelli, Marco Metra, Lars H Lund
European Heart Journal|August 18, 2022
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?Bertram Pitt, Deepak L Bhatt, Marco Metra
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Current guidelines in the pharmacological management of chronic heart failureMarco Metra, Savina Nodari, Livio Dei Cas
JAMA Cardiology|August 22, 2020
Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease-ReplyRiccardo M Inciardi, Laura Lupi, Marco Metra
Pageof 133